Want real case studies? 10 seconds to sign up
Join the platform
January 20, 2026
Approximately 5 minutes
Reviewed by Nate Lam, Founder & Director, ElendiLabs
Slovakia Act No. 362/2011 §46(5): Authorized Representative Notification of Serious Incidents
1. Legal Provision Text
Paragraph 46(5) states that the authorized representative shall immediately notify the competent authority of any serious incident or field safety corrective action involving a medical device for which he acts as the authorized representative, in accordance with the special regulation on vigilance. Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
2. Scope of Notification Obligation
The AR must report:
- Serious incidents (death, serious deterioration in health, serious public health threat)
- Field safety corrective actions (FSCA) initiated by the manufacturer
- Any corrective or preventive action taken in response to incidents
- Incidents occurring with devices placed on the Slovak market by non-EU manufacturers
Notification is immediate and follows vigilance procedures. Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
3. Reporting Timeline and Process
- Immediate notification upon becoming aware of the incident
- Use ŠÚKL vigilance reporting forms/system
- Provide initial report within required timeframe (typically 10 days for serious incidents)
- Follow-up reports as new information becomes available
- Coordinate with manufacturer for joint reporting where possible
Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
4. MDR Transition Application
For legacy devices under MDD transitional provisions (MDR Article 120):
- §46(5) vigilance notification continues until MDD certificate expiry
- After transition, MDR Article 11(5) and Article 87 impose enhanced vigilance obligations on ARs
- ARs must prepare for stricter MDR reporting timelines and EUDAMED integration
Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
5. Practical RA Guidance for ARs
- Establish 24/7 incident awareness and escalation protocol
- Maintain direct communication channel with manufacturer vigilance team
- Train local staff on serious incident criteria and reporting
- Keep audit trail of all ŠÚKL notifications and follow-ups
- Integrate vigilance reporting into QMS for traceability
- Prepare template for initial and follow-up reports
Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
6. Common Vigilance Reporting Challenges
- Delays in receiving incident details from manufacturer
- Uncertainty on serious incident classification
- Language barriers in reporting to ŠÚKL
- Coordination issues during FSCA implementation
- Incomplete manufacturer root cause analysis
Source: Act No. 362/2011 Coll. §46(5) practical notes (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
7. RA Vigilance Checklist for ARs
- Is there a 24/7 contact for incident alerts?
- Are serious incident criteria clearly documented?
- Is ŠÚKL reporting form/template ready?
- Is manufacturer-AR vigilance agreement in place?
- Are past reports logged and reviewed?
- Is escalation protocol tested annually?
Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
8. Enforcement and Non-Compliance Risks
Failure to notify may lead to:
- Administrative fines
- Order to cease distribution
- Potential criminal sanctions in severe cases
- Reputational damage and loss of authorization
Source: Act No. 362/2011 Coll. enforcement provisions (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
9. Alignment with MDR Vigilance Requirements
While §46(5) aligns with MDD vigilance, MDR Articles 87–89 introduce:
- Stricter timelines (e.g., 15/10/2 days depending on severity)
- Mandatory EUDAMED reporting
- Trend reporting obligations
- Periodic safety update reports (PSUR) for certain devices
ARs should enhance vigilance processes for MDR readiness. Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
10. Best Practices for Effective Vigilance
- Conduct regular vigilance training and simulations
- Use secure digital platform for manufacturer-AR communication
- Maintain bilingual vigilance documentation
- Review all ŠÚKL feedback on reports
- Participate in EU vigilance networks for harmonization
Source: Act No. 362/2011 Coll. §46(5) (https://www.slov-lex.sk/ezbierky/pravne-predpisy/SK/ZZ/2011/362/#paragraf-46.odsek-5)
Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
Registered Pharmacist · AI Engineer · Director, ElendiLabs
Registered pharmacist, AI engineer, HKHAIS founder, and pharmaceutical & medical device SEO/GEO specialist.
Ask Anything
We'll follow up with you personally.
100% response rate • Reply within 7 business days
Related Articles
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 10: Post-Market Surveillance and Vigilance Reporting Obligations for Medical Devices
Annex 10 to Decree No. 158/2015 Z.z. outlines the mandatory post-market surveillance (PMS), vigilance reporting, trend analysis, periodic safety update reports (PSUR), and field safety corrective action (FSCA) requirements for medical devices in Slovakia, transposed from MDD Annex II/III/V/VI and applicable to legacy devices during MDR transition.
Approximately 5 minutes
Slovakia Act No. 362/2011 §6(1)(c): Definition and Scope of Custom-Made Medical Devices
Section 6(1)(c) of Slovak Act No. 362/2011 defines custom-made medical devices as those manufactured specifically according to a written prescription from a qualified healthcare professional to meet the unique needs of an individual patient, distinguishing them from mass-produced devices and exempting them from standard registration under certain conditions.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 1: Classification Rules for Medical Devices
Annex 1 to Slovak Decree No. 158/2015 Z.z. sets out the detailed classification rules for medical devices in Slovakia, implementing the classification criteria of EU Directive 93/42/EEC (Annex IX), including 18 rules covering non-invasive, invasive, active devices, and special cases such as software and combination products, used to determine Class I, IIa, IIb or III.
Approximately 5 minutes
Slovakia Act No. 362/2011 §141(1)(b): Vigilance Reporting Obligations for Serious Incidents
Under §141(1)(b) of Act No. 362/2011 Coll., manufacturers, authorised representatives, importers and distributors in Slovakia must immediately report to the State Institute for Drug Control (ŠÚKL) any serious incident or field safety corrective action involving a medical device, including details of the event, risk assessment and proposed measures, to ensure rapid response and patient safety.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 2: List of Classified Medical Devices and Examples
Annex 2 to Decree No. 158/2015 Z.z. provides a non-exhaustive illustrative list of medical devices with their assigned risk classes in Slovakia, based on the classification rules of Annex 1 (transposing MDD Annex IX), serving as a practical reference for manufacturers and RA professionals to determine conformity assessment requirements for common device types.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 3 Part A: Information Requirements for Class I Medical Devices
Annex 3 Part A of Decree No. 158/2015 Z.z. specifies the mandatory information that manufacturers must provide to the State Institute for Drug Control (ŠÚKL) when registering or notifying Class I medical devices in Slovakia, including device details, classification justification, risk management summary, labelling, and instructions for use, as transposed from MDD requirements.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 3 Part B: Information Requirements for Higher Risk Medical Devices
Annex 3 Part B of Decree No. 158/2015 Z.z. outlines the detailed information and documentation that manufacturers must submit to ŠÚKL for Class IIa, IIb and III medical devices in Slovakia, including full technical documentation excerpts, conformity assessment certificates, vigilance summaries and periodic safety update reports, as required under the MDD framework.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 5 Part A §1(e): Mandatory Anti-HBc Testing for Blood Donors
Under Annex 5 Part A §1(e) of Decree No. 158/2015 Z.z., all blood donors in Slovakia must undergo mandatory testing for antibodies to hepatitis B core antigen (anti-HBc) as part of the required infectious marker screening to ensure blood safety and prevent HBV transmission via transfusion.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 6: Requirements for Clinical Evaluation and Performance Studies of IVDs
Annex 6 to Decree No. 158/2015 Z.z. establishes the detailed requirements for clinical evaluation, performance studies, scientific validity, analytical and clinical performance of in vitro diagnostic medical devices (IVDs) in Slovakia, transposing key elements of Directive 98/79/EC Annex III and serving as guidance for manufacturers during the IVDR transitional period.
Approximately 5 minutes
Slovakia Act No. 362/2011 §141(1)(b): Mandatory Serious Incident Reporting for Medical Devices
Section 141(1)(b) of Act No. 362/2011 Coll. imposes an immediate reporting duty on manufacturers, authorised representatives, importers and distributors to notify the State Institute for Drug Control (ŠÚKL) of any serious incident or field safety corrective action involving a medical device placed on the Slovak market, ensuring rapid national response and patient protection under the MDD-transposed framework.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 3 Part B: Documentation Obligations for Class IIa/IIb/III Devices
Annex 3 Part B of Decree No. 158/2015 Z.z. details the comprehensive documentation and information that manufacturers and authorized representatives must submit to ŠÚKL for higher-risk medical devices (Class IIa, IIb, III) in Slovakia, including certificates, technical summaries, risk management excerpts, labelling in Slovak, and vigilance data, under the MDD-transposed regime.
Approximately 5 minutes
Slovakia Decree No. 158/2015 Annex 8: Requirements for Sterilisation Validation of Medical Devices
Annex 8 to Decree No. 158/2015 Z.z. sets out the mandatory sterilisation validation and assurance requirements for sterile medical devices in Slovakia, including process validation, sterility assurance level (SAL), packaging, labelling, and periodic revalidation, transposed from MDD Annex I essential requirements and harmonised standards.
Approximately 5 minutes
Slovakia Decree No. 158/2015 §2(2): Definition of Medical Device and Scope of Regulation
Section 2(2) of Decree No. 158/2015 Z.z. provides the precise legal definition of a 'medical device' in Slovakia, including key criteria such as intended purpose, principal intended action, and exclusions, serving as the foundational scope for all regulatory obligations under the MDD-transposed framework.
Approximately 5 minutes
Slovakia Act No. 362/2011 §141(1)(b): Immediate Reporting Duty for Serious Incidents and FSCA
Under §141(1)(b) of Act No. 362/2011 Coll., manufacturers, authorised representatives, importers and distributors must immediately notify ŠÚKL of any serious incident or field safety corrective action involving a device on the Slovak market, transposing MDD vigilance requirements and applicable to legacy devices in the MDR transition.
Approximately 5 minutes
Slovakia Act No. 362/2011 §124a(4)(d): Authorized Representative Obligations for Foreign Manufacturers
Section 124a(4)(d) of Act No. 362/2011 Coll. requires the authorized representative of a non-EU manufacturer to keep available and provide upon request to ŠÚKL the technical documentation, declaration of conformity, and certificates for medical devices placed on the Slovak market, ensuring regulatory oversight and traceability under the MDD-transposed framework.
Approximately 5 minutes
Slovakia Act No. 362/2011 §103: Authorized Representative Registration and Notification Requirements
Section 103 of Act No. 362/2011 Coll. mandates that authorized representatives established in Slovakia must register with ŠÚKL before commencing activities, notify changes in registration details, and provide annual confirmations of continued authorization for non-EU manufacturers under the MDD-transposed regime.
Approximately 5 minutes
Slovakia Act No. 362/2011 §124b(6): Joint Liability of Authorized Representative for Defective Medical Devices
Section 124b(6) of Act No. 362/2011 Coll. establishes joint and several liability of the authorized representative with the non-EU manufacturer for any damage caused by defective medical devices placed on the Slovak market, transposing product liability protections under the MDD framework.
Approximately 5 minutes
Slovakia Act No. 362/2011 §126(5): Distributor Obligations for Medical Device Compliance Verification
Section 126(5) of Act No. 362/2011 Coll. mandates distributors to verify that medical devices comply with regulatory requirements, including conformity marking, labelling, and instructions in Slovak, before distribution in Slovakia, ensuring market surveillance under the MDD-transposed regime.
Approximately 5 minutes
Slovakia Act No. 362/2011 §6(4)(f)(1): Exemption from Registration for Custom-Made Medical Devices
Under Slovak Act No. 362/2011 on Medicinal Products and Medical Devices, custom-made medical devices are exempt from registration with the State Institute for Drug Control (ŠÚKL) if they meet specific conditions under §6(4)(f)(1), allowing faster market access for patient-specific devices while maintaining manufacturer responsibility for safety and documentation.
Approximately 5 minutes
Slovakia Act No. 362/2011 §46(4): Authorized Representative Record-Keeping and Documentation Duties
Section 46(4) of Act No. 362/2011 Coll. requires the authorized representative to keep and make available to the competent authority all relevant documentation concerning the medical devices for which he acts as representative, including technical files, declarations of conformity, and vigilance records, ensuring traceability under the MDD-transposed regime.